Arginase 1 contributes to diminished coronary arteriolar dilation in patients with diabetes
about
Targeting Nitric Oxide with Natural Derived Compounds as a Therapeutic Strategy in Vascular DiseasesAge-related impairment of conducted dilation in human coronary arteriolesAn urea, arginine and carnosine based cream (Ureadin Rx Db ISDIN) shows greater efficacy in the treatment of severe xerosis of the feet in Type 2 diabetic patients in comparison with glycerol-based emollient cream. A randomized, assessor-blinded, coDiabetic nephropathy is resistant to oral L-arginine or L-citrulline supplementationIs arginase a potential drug target in tobacco-induced pulmonary endothelial dysfunction?Arginase-2 mediates diabetic renal injury.Oxidative species increase arginase activity in endothelial cells through the RhoA/Rho kinase pathway.Diabetes-induced vascular dysfunction involves arginase IEndothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing.Adipokine Imbalance in the Pericardial Cavity of Cardiac and Vascular Disease PatientsTissue-specific up-regulation of arginase I and II induced by p38 MAPK mediates endothelial dysfunction in type 1 diabetes mellitus.Arginase promotes skeletal muscle arteriolar endothelial dysfunction in diabetic ratsArginase 1: an unexpected mediator of pulmonary capillary barrier dysfunction in models of acute lung injury.Vasomotor regulation of coronary microcirculation by oxidative stress: role of arginase.Development of novel arginase inhibitors for therapy of endothelial dysfunctionSelective up-regulation of arginase-1 in coronary arteries of diabetic patients.Coronary endothelial dysfunction and mitochondrial reactive oxygen species in type 2 diabetic mice.l-Citrulline Protects from Kidney Damage in Type 1 Diabetic Mice.Peroxynitrite disrupts endothelial caveolae leading to eNOS uncoupling and diminished flow-mediated dilation in coronary arterioles of diabetic patients.Cutaneous vasodilator and vasoconstrictor mechanisms in temperature regulation.Arginase: an old enzyme with new tricks.The eNOS signalosome and its link to endothelial dysfunction.Arginase Inhibitors: A Rational Approach Over One Century.Activation of hexosamine pathway impairs nitric oxide (NO)-dependent arteriolar dilations by increased protein O-GlcNAcylation.Augmented oxidative stress and preserved vasoconstriction induced by hydrogen peroxide in coronary arteries in obesity: role of COX-2.Obesity-induced vascular dysfunction and arterial stiffening requires endothelial cell arginase 1.Obesity-induced vascular inflammation involves elevated arginase activity.Vasodilator Dysfunction and Oligodendrocyte Dysmaturation in Aging White Matter.Differential expression of genes identified by suppression subtractive hybridization in liver and adipose tissue of gerbils with diabetes.Mechanisms of Diabetes-Induced Endothelial Cell Senescence: Role of Arginase 1.Deletion of endothelial arginase 1 does not improve vasomotor function in diabetic mice.single nucleotide polymorphisms rs2781666 and rs2781665 confer risk of Type 2 diabetes mellitus
P2860
Q28073279-A4781DCD-3AD6-41EE-BD69-38AA2354ED82Q33764615-FA426E13-7347-4479-81A8-772011E80438Q34420978-5EB4ACCC-CA77-46B0-AE16-F5DF26E28FFCQ34627559-698EC9AD-AE52-474C-8F7A-0B2A2ABACF41Q35339312-002F9DF8-16DF-493B-BC37-29FE702FAD71Q35405005-081EFE61-54EE-42BA-A3F0-66FE42782B08Q35708220-9883F9D7-EBAE-4642-AC21-E75AAD557114Q35906453-85BE0444-09DC-4BF6-9A07-7543D0942F81Q35947546-1F2CB4FE-6A6D-44D8-B516-9E699961914BQ36006923-9CDD3ECC-7E8F-46CD-AB3A-2DC377A975AEQ36124220-6211761B-94F0-40DF-80AD-59AF012B0E1FQ36854784-12842D7F-AC94-4061-8409-77D2C7DD3E6BQ37076835-5C81EF0B-6366-4FAD-B85A-25045CF2A6C7Q37102697-D8F25666-BC85-487D-B684-1957A77AB48EQ37176702-C245FF1A-AC5B-4443-9CC3-F81D1D4BBAC9Q37199274-19583711-B7D8-4635-87F3-8D3FD289EC55Q37341923-47736DB0-47AC-4F12-A194-72B62225056EQ37412089-19C965D1-811B-4EC8-B18E-E7D1F27346CFQ37660941-17CEDCA6-070A-410C-928E-25B529C8C403Q38201379-9F26990A-48C7-4017-810C-7A987545127FQ38452432-BCF6EC9A-244D-47AD-8F5F-2F22C593B151Q38835675-4C519C8C-01F9-4827-9EF4-EA36D4AB7372Q39012928-23AD2B2B-731D-4586-9C76-CE5E7E10793DQ42160397-846065EB-DCF2-43C4-A08B-A13E04AEBC21Q42709939-6BAEFB52-92F2-4088-869D-771A268B824DQ47734746-BD4A5C68-BECE-4320-8495-0C3802C47DC2Q47789699-F7F12BDE-03AA-4959-B36B-A9584577A49BQ47892663-ED461D44-D90B-4AFF-9821-D20C45A10E65Q48114214-70759D01-80E6-4895-9DD6-6666E8EB2331Q55153776-7B9252D0-F957-40B7-AF8B-3DFC91657AD9Q55242323-2ADC21A6-034B-42D6-8D5E-4B736C53FC68Q58700252-EFDA00A3-35B8-4C32-8F40-4D1929A7DE45
P2860
Arginase 1 contributes to diminished coronary arteriolar dilation in patients with diabetes
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Arginase 1 contributes to dimi ...... tion in patients with diabetes
@ast
Arginase 1 contributes to dimi ...... tion in patients with diabetes
@en
Arginase 1 contributes to dimi ...... tion in patients with diabetes
@nl
type
label
Arginase 1 contributes to dimi ...... tion in patients with diabetes
@ast
Arginase 1 contributes to dimi ...... tion in patients with diabetes
@en
Arginase 1 contributes to dimi ...... tion in patients with diabetes
@nl
prefLabel
Arginase 1 contributes to dimi ...... tion in patients with diabetes
@ast
Arginase 1 contributes to dimi ...... tion in patients with diabetes
@en
Arginase 1 contributes to dimi ...... tion in patients with diabetes
@nl
P2093
P2860
P1476
Arginase 1 contributes to dimi ...... tion in patients with diabetes
@en
P2093
Attila Feher
David Spielvogel
Steven L Lansman
Timea Beleznai
Zsolt Bagi
P2860
P304
P356
10.1152/AJPHEART.00831.2010
P577
2011-01-07T00:00:00Z